SmallCap
CompaniesMapStatistics

㈜알테오젠

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name㈜알테오젠
Business Reg. No.3148197965
CEO전태연
Address대전광역시 유성구
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products항체 바이오시밀러 및 바이오베터 의약품 연구개발
EstablishedContact
Phone042-384-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.160111-*******

Investment Metrics


Market Cap
-
Op. Margin
32.95%
ROE
15.66%
Debt Ratio
10.14%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2009-08-24 ~ 2011-08-23200901076512009-08-24
벤처투자유형2011-08-24 ~ 2013-08-23201103001892009-08-24
벤처투자유형2013-08-24 ~ 2015-08-23201303001942009-08-24
벤처투자유형2015-08-24 ~ 2017-08-23201503002992009-08-24
벤처투자유형2017-08-24 ~ 2019-08-23201703004022009-08-24
연구개발유형2019-08-24 ~ 2021-08-23201901080022009-08-24
연구개발유형2021-08-24 ~ 2024-08-23202107210200662009-08-24
연구개발유형2024-08-24 ~ 2027-08-23202408210200042009-08-24

Financial Statements


3-Year Financial Data

Revenue CAGR +226.0%

Item202420232022
Revenue

930B

835B

87B

Operating Profit

306B

-9.0B

-215B

Net Profit

471B

49B

21B

Total Assets

3,316B

2,039B

1,858B

Total Liabilities

305B

174B

86B

Total Equity

3,011B

1,865B

1,773B

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
930B

101.6%

vs. 3-Year Avg.: 461B
Operating Profit
306B

373.8%

vs. 3-Year Avg.: -112B
Op. Margin
32.9%

126.7%

vs. 3-Year Avg.: -123.2%
Debt Ratio
10.1%

42.9%

vs. 3-Year Avg.: 7.1%
ROE
15.7%

722.3%

vs. 3-Year Avg.: 1.9%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
전태연대표이사대표

Employment Status


Regular EmployeesContact
CEO전태연

Patent Status

Updated: 2026-02-25

40 Patents
19 Registered
8 in 3 Years
A61 의학/수의학/위생 (104)
C07 유기화학 (42)
C12 생화학/미생물학 (26)
B65 운반/포장/저장 (1)
G01 측정/시험 (1)
Patent TitleApplicantApplication No.Filing DateStatus
신규한 항-Ang-2 항체 및 이의 용도주식회사 알테오젠바이오로직스10202500239462025-02-24공개
재조합 히알루로니다제의 생산 방법(주)알테오젠10202401705252024-11-26공개
N-말단 및/또는 C-말단이 절단된 가용성 PH20 폴리펩티드 및 이의 용도(주)알테오젠10202400872542024-07-03��개
신규 히알루론산 가수분해 효소 변이체 및 이를 포함하는 약제학적 조성물(주)알테오젠10202570316752024-03-21공개
재조합 히알루로니다제의 생산 방법(주)알테오젠10202400363082024-03-15등록

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "대전광역시 유성구",
  "ceo_name": "전태연",
  "certificate": [
    {
      "cert_number": "20090107651",
      "changes": "",
      "disclosure_date": "2009-08-24",
      "first_cert_date": "2009-08-24",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2009-08-24 ~ 2011-08-23"
    },
    {
      "cert_number": "20110300189",
      "changes": "",
      "disclosure_date": "2011-08-25",
      "first_cert_date": "2009-08-24",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2011-08-24 ~ 2013-08-23"
    },
    {
      "cert_number": "20130300194",
      "changes": "",
      "disclosure_date": "2013-07-18",
      "first_cert_date": "2009-08-24",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2013-08-24 ~ 2015-08-23"
    },
    {
      "cert_number": "20150300299",
      "changes": "",
      "disclosure_date": "2015-07-28",
      "first_cert_date": "2009-08-24",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2015-08-24 ~ 2017-08-23"
    },
    {
      "cert_number": "20170300402",
      "changes": "",
      "disclosure_date": "2017-07-20",
      "first_cert_date": "2009-08-24",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2017-08-24 ~ 2019-08-23"
    },
    {
      "cert_number": "20190108002",
      "changes": "",
      "disclosure_date": "2019-07-10",
      "first_cert_date": "2009-08-24",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2019-08-24 ~ 2021-08-23"
    },
    {
      "cert_number": "20210721020066",
      "changes": "",
      "disclosure_date": "2021-07-21",
      "first_cert_date": "2009-08-24",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2021-08-24 ~ 2024-08-23"
    },
    {
      "cert_number": "20240821020004",
      "changes": "대표자",
      "disclosure_date": "2024-08-21",
      "first_cert_date": "2009-08-24",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2024-08-24 ~ 2027-08-23"
    }
  ],
  "company_name": "㈜알테오젠",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 26207738000,
      "cost_of_sales": 5493546000,
      "current_assets": 111923741000,
      "current_liabilities": 6754226000,
      "gross_profit": 3256373000,
      "net_income": 2114428000,
      "net_income_bs": 2114428000,
      "non_current_assets": 73920649000,
      "non_current_liabilities": 1834447000,
      "non_operating_expenses": 419748000,
      "non_operating_income": 24005074000,
      "operating_profit": -21470898000,
      "revenue": 8749919000,
      "sga_expenses": 24727271000,
      "total_assets": 185844390000,
      "total_equity": 177255717000,
      "total_liabilities": 8588673000
    },
    "2023": {
      "capital_stock": 26505914000,
      "cost_of_sales": 51796660000,
      "current_assets": 131162259000,
      "current_liabilities": 15908592000,
      "gross_profit": 31681716000,
      "net_income": 4876840000,
      "net_income_bs": 4870809000,
      "non_current_assets": 72780589000,
      "non_current_liabilities": 1506828000,
      "non_operating_expenses": 1794573000,
      "non_operating_income": 7575738000,
      "operating_profit": -904325000,
      "revenue": 83478376000,
      "sga_expenses": 32586041000,
      "total_assets": 203942848000,
      "total_equity": 186527428000,
      "total_liabilities": 17415420000
    },
    "2024": {
      "capital_stock": 26659414000,
      "cost_of_sales": 29452400000,
      "current_assets": 181866457000,
      "current_liabilities": 24926555000,
      "gross_profit": 63516645000,
      "net_income": 47141705000,
      "net_income_bs": 71232721000,
      "non_current_assets": 149781556000,
      "non_current_liabilities": 5594527000,
      "non_operating_expenses": 1460926000,
      "non_operating_income": 17972800000,
      "operating_profit": 30629831000,
      "revenue": 92969045000,
      "sga_expenses": 32886814000,
      "total_assets": 331648013000,
      "total_equity": 301126931000,
      "total_liabilities": 30521082000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "9,999,990,000",
      "changes": "9,999,990,000",
      "date": "2016-09-07"
    }
  ],
  "main_products": "항체 바이오시밀러 및 바이오베터 의약품 연구개발",
  "phone": "042-384-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
Employment Insurance2026-02-25
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected